AstroNova, Inc. Liquidation Value

AstroNova, Inc. (ALOT) as of January 31, 2026 presents a materially negative liquidation recovery posture. MFFAIS-reported CLV of -$54.5M and LLV of -$35.6M confirm this quantitatively. The OLV of +$7.7M reflects residual value only in operating assets after applying the standard haircut schedule, before settling liabilities at face value.

Asset-side recovery is constrained by three factors. First, inventory at $43.3M net book value (gross $52.0M less $8.7M reserve) represents the single largest current asset, but at a 60% recovery haircut yields approximately $26M — a $17M value destruction relative to carrying amount. Second, intangible assets of $21.5M net (gross $42.6M, accumulated amortization $21.7M) and goodwill of $17.4M are assigned zero recovery under the liquidation lens, collectively destroying approximately $38.9M of reported asset value. Third, the $9.8M net deferred tax asset is non-realizable in a wind-down scenario.

The liability stack has worsened since the prior 10-Q period (ended October 31, 2025). Total long-term debt carrying value at January 31, 2026 is $21.4M, down from $25.2M at January 31, 2025 (prior year-end), reflecting paydown under the refinanced Bank of America credit agreement executed October 31, 2025 (Sixth Amendment). The revolving credit facility shows $16.3M drawn as current debt. Combined funded debt is approximately $21.4M face value across term loans plus a residual equipment note plus assumed MTEX obligations. Purchase commitments of $23.3M ($22.9M due within 12 months) represent an off-balance-sheet production obligation that does not extinguish on wind-down and is not reflected in reported current liabilities — this is a material liquidation liability gap. ASC 842 operating lease obligations total $2.5M ($0.6M current, $1.9M long-term), small relative to total liabilities but accrue at face value.

The allowance for doubtful accounts increased sharply from $618K (FY2024) to $3.1M (FY2025) to $2.3M (FY2026 after $1.1M write-off), indicating elevated AR credit quality deterioration in recent periods that modestly compresses gross-to-net AR recovery. The goodwill impairment charge of $297K in FY2026 (Product ID segment) is de minimis against the $17.4M goodwill balance but signals impairment pressure in that segment. Restructuring costs of $1.4M were incurred in FY2026, with $244K of accrued severance remaining as a liability at period-end. A EUR 5.2M ($6.0M) arbitration claim from former MTEX sellers (Effort/Ferreira) is disclosed as a contingency with no reserve recorded; counterclaims of EUR 22.3M are asserted but are not assets in a liquidation frame. The FY2026 net loss of $2.4M (improved sharply from $14.5M in FY2025, which included heavy goodwill and other charges) does not affect the static liquidation calculation but signals the company is still consuming equity through operations.